Article
Synergistic effect of perampanel with temozolomide on glioblastoma cells in vivo
2025-03-01
Abstract excerpt
The anti-epileptic drug perampanel, an α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor antagonist, exhibits anti-tumor effects against glioblastoma cells in vitro. This study examined the anti-tumor effects of combination therapy with temozolomide and perampanel on glioblastoma cells both in vitro and in vivo to assess the potential for clinical application. The commercially available glioblastoma cell...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 09ee07c4-9ebf-51a5-87b2-dea367c5b3af
- DOI
- 10.1016/j.heliyon.2025.e43167
